赛默飞世尔在ASMS 2026发布新一代创新技术,加速从药物发现到新疗法的进程

美股速递
May 28

赛默飞世尔在2026年美国质谱学会年会上,揭晓了其新一代突破性技术。这些创新旨在显著缩短药物研发周期,并加速新型疗法从实验室走向临床应用的转化路径。

公司展示了一系列前沿解决方案,覆盖从靶点识别到临床前研究的全链条。通过整合先进的分析工具与自动化平台,新系统有望提升科研效率与数据可靠性,为生物医药行业带来变革性动力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10